Ferrovir 15 mg/ml solution for intramuscular injection 5 ml vial 5 pcs.

Ferrovir® is used in adults aged 18 and older.
It is used in combination therapy for patients infected with HIV (Human Immunodeficiency Virus) and patients with AIDS (Acquired Immunodeficiency Syndrome);
HIV-infected patients with hepatitis C;
HIV-infected patients with recurrent herpes infection.
For the treatment of patients with tick-borne encephalitis, hepatitis C, herpes.

Always use the medication in full accordance with the recommendations of your treating physician. If in doubt, consult your treating physician.

Recommended dosage:
The dosage of the medication and the duration of use are determined by the treating physician depending on the condition.
Adults
Single dose - 75.24 mg
Daily dose - 150.48 mg
In the treatment of HIV infection or AIDS, adults are prescribed the medication intramuscularly: 5 ml of the solution for intramuscular injection twice a day for 14 days. If necessary, depending on the dynamics of T4 lymphocyte counts and the level of HIV-1 RNA in peripheral blood, a repeat course of therapy may be prescribed after 1-1.5 months.
In the case of tick-borne encephalitis, the medication is administered twice a day at 5 ml of the solution for intramuscular injection for 5 - 10 days.
In the treatment of hepatitis C, the medication is administered intramuscularly twice a day at 5 ml of the solution for intramuscular injection for 14 days. In the following 14 days, the medication is administered at the same daily dose every other day.
In the treatment of herpes - 5 ml of the solution for intramuscular injection twice a day for 10 days.

Route and method of administration
The medication will be administered to you by a healthcare professional. It is injected intramuscularly, slowly over 1-2 minutes.
If you have any questions regarding the use of the medication, please consult your treating physician or nurse.

The Ferrovit® preparation contains
Active ingredient: sodium deoxyribonucleate with iron complex.
Each ml contains 15.05 mg of sodium deoxyribonucleate with iron complex.
Each vial contains 75.24 mg of sodium deoxyribonucleate with iron complex in 5 ml of solution.
Excipients: water for injections.

The Ferrovit® preparation contains sodium (see section 2).

Transparent yellow liquid.

Do not take the Ferrovit® if:

• you are allergic to sodium deoxyribonucleate with iron complex or any other components of the product (listed in section 6 of the leaflet);

• you are pregnant;

• you are breastfeeding.

Before using the Ferrovit® medication, consult your treating physician.
The medication will be administered to you by a healthcare professional. The medication is injected intramuscularly, slowly over 1-2 minutes.
Intravenous administration of the medication is not permitted.

Children
Do not give the medication to children aged 0 to 18 years, as efficacy and safety have not been established.

The Ferrovit® medication contains sodium
The medication contains less than 1 mmol (23 mg) of sodium per 5 ml.

Like all medications, it may cause undesirable reactions; however, they do not occur in everyone.
Possible short-term increase in body temperature (up to 38ºC), skin redness (hyperemia), and moderate pain at the injection site.

Reporting undesirable reactions
If you experience any undesirable reactions, consult your doctor. This recommendation applies to any possible undesirable reactions, including those not listed in the leaflet. You can also report undesirable reactions directly through the reporting system of the member states of the Eurasian Economic Union (see below). By reporting undesirable reactions, you help gather more information about the safety of the medication.

No negative effects from overdose have been identified.

Inform your healthcare provider about any other medications you are currently taking, have recently taken, or may start taking. It is especially important to inform your doctor if you are using the following medications:

• anticoagulants (medications for the prevention of thrombosis);

• antibiotics (medications for the treatment of bacterial diseases);

• antivirals (medications for the treatment of viral diseases);

• antifungals (medications for the treatment of fungal diseases);

• cytostatics (medications for the treatment of oncological diseases, rheumatoid arthritis).

What is the Ferrovit® preparation and what is it used for
The Ferrovit® preparation contains the active ingredient sodium deoxyribonucleate with iron complex and is an antiviral medication.

Mechanism of action of the Ferrovit® preparation

The preparation exhibits antiviral and immunomodulatory effects, activating antiviral, antifungal, and antimicrobial immunity. It demonstrates antiviral activity against RNA- and DNA-containing viruses. The preparation is characterized by a high degree of activity against various fungal, bacterial, and viral infections occurring in the context of immunodeficiency, which can lead to serious illnesses in the patient.

If improvement does not occur or you feel worse, it is necessary to consult a doctor.